Navigation Links
AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
Date:5/7/2008

royalties 7,942 7,204

License fees 1,806 2,029

-----------------------

9,748 9,233

-----------------------

Operating expenses

Cost of sales 4,604 3,310

Selling, general and administrative 4,404 4,892

R&D costs, net of tax credits 13,689 7,907

Depreciation and amortization 1,209 1,427

-----------------------

23,906 17,536

-----------------------

Loss from operations (14,158) (8,303)

Other revenues net of expenses 3,292 616

Income tax recovery - 2,544

-----------------------

Net loss from continuing operations (10,866) (5,143)

Net earnings from discontinued operations - 33

-----------------------

Net loss (10,866) (5,110)

-----------------------

-----------------------

Net loss per share from continuing operations

Basic and diluted (0.20) (0.10)

Net earnings per share from discontinued

operations

Basic and diluted
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...vestment bank KTA Capital,s client Neuren Pharmace...vertible note private placement with a U.S. instit...ed by KTA Capital as Neuren,s exclusive placement ...York (PRWEB) November 23, 2009 -- The independent ...TA Capital") has announced that its client Ne...
(Date:11/24/2009)..., Nov. 24 Dow AgroScienc...ts of Hyland Seeds, a division of Thompsons Limite...ds will further expand Dow AgroSciences, current s...duction of SmartStax(TM) in 2010 and Dow Agr...orn in 2012. The transactional close is expected i...
(Date:11/24/2009)...wire-FirstCall/ -- Sigma-Aldrich Corporation (Nasd...onference on Tuesday, December 1st at 1:45 PM GMT ...listen via live audio broadcast over the Internet ...drich.com/ . Users can click the "Webcast" icon ...: Sigma-Aldrich is a leading Life Science and Hi...
(Date:11/24/2009)...celand, November 24 deCO...the approval of all of its,"first day" motions by ...ware,(the "Bankruptcy Court"). deCODE last week fi...11 of the United States Bankruptcy Code with the,B...he Bankruptcy Court allow the company to continue,...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...s and scientists at The University of Texas at Aus...ne-atom thick structure called "graphene" as a new...ge in ultracapacitor devices, perhaps paving the w...ies such as wind and solar power. , The researche...raphene (a form of carbon) could eventually double...
...ss., Sept. 16 Inverness Medical,Innovations, Inc....r of rapid,diagnostic products for the consumer an...wanziger, Chairman, Chief Executive Officer and,Pr... will be attending the,Goldman Sachs Diagnostics C...ork City in order to meet with current and prospec...
....J., Sept. 16 Barr,Pharmaceuticals, Inc. (NYSE: ...boratories, Inc., received final approval from the...ure and market a generic version of Ortho,McNeil J...extended release,capsules), eq. to 8 mg, 16 mg and...ompany to file an Abbreviated New Drug Application...
Other Biology Technology:New carbon material shows promise of storing large quantities of renewable electrical energy 2New carbon material shows promise of storing large quantities of renewable electrical energy 3Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules 2Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules 3Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules 4Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules 5
(Date:11/24/2009)...tarctica has long held secrets of the earth,s hist...there has been very little information on the envi...e for millions of years. Now, a team of researcher... funded to the tune of $10 million dollars by the ... bottom of things literally. These scientists wil...
(Date:11/24/2009)...ovember 24, 2009) New research on bacterial commu...s reveals predictable temporal patterns, suggestin...arkers for monitoring climate change in the polar ...oceedings of the National Academy of Sciences Ear...e six rivers shifted synchronously over time, corr...
(Date:11/23/2009)...earch presents strong evidence that the "synergist...traffic-related pollution and indoor endotoxin cau...other exposure alone. , Environmental health s...lege of Medicine have shown that children exposed ...nd indoor endotoxin during early life are six time...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Face Masks for Patients May Leak Spread Germs 59226 1Face Masks for Patients May Leak Spread Germs 59226 2Amended Chairmans Mark Sets Stage for 26quot 3BHitting Bulls eye in Health Reform 26quot 3B 59224 1Amended Chairmans Mark Sets Stage for 26quot 3BHitting Bulls eye in Health Reform 26quot 3B 59224 2U S Bishops 3A Current Health Care Bills Violate Essential Principles 3B Will Seek Changes or Have to Oppose 59222 1U S Bishops 3A Current Health Care Bills Violate Essential Principles 3B Will Seek Changes or Have to Oppose 59222 2
...oti, Ph.D., M.D. (h.c.), chief executive officer o...CR), today received the inaugural Margaret Kripke ...derson Cancer Center. , The Kripke Legend award ... made extraordinary efforts to hire a diverse work... women for awards and otherwise advance their care...
... in German . , Helsinki/Leipzig. Specific meas...rading, will only be successful if they are cohere...sing economic and social issues, says a report pub...onmental Research (PEER). PEER membership is forme... research institutes. , The report explains that...
... 2009 Researchers led by a Texas A&M University p...of Hawaii that are more than 4,200 years old, maki.... , The team, directed by Brendan Roark of Texas A...he University of California-Santa Cruz and Austral...r work published in the current Proceedings of th...
Other Biology News:M. D. Anderson gives first Margaret Kripke Legend Award to Margaret Foti 2M. D. Anderson gives first Margaret Kripke Legend Award to Margaret Foti 3Climate change aims need to be better integrated 24,000-year-old coral beds among world's oldest living things, prof says 2
...ng: High, 400 ng IgG/cm 2 (1cm2 = 100 µl vo...erformance Certified: Well-to-Well, CV =3% , Well ...icro;l , Packaging: 5 plates per sealed tray ,Fe...ation , High antibody binding surface improves the...
...or SFC and SFE applications based upon the modular... recently added the following modules to enhance t...livery pump for supercritical fluid chromatography... the mobile phase. ,- The BP-1580-81 automatic bac...
CERTOMAT R from Sartorius AG
Affy Microarray Expression Analysis from Seqwright
Biology Products: